Eliminating spurious, fake medicines: Govt to mandate pharma cos to print bar code on 300 drug formulations

Based on the comments and further deliberations, the ministry is in the process of finalising it.

Manufacturers of 300 drug formulation products as specified in the Schedule H2 of the Rule 96 of Drugs and Cosmetics Act ,will be required to print or affix bar code or quick response code on its primary packaging or secondary package label that store data or information legible with software application to facilitate authentication.

The stored data or information shall include particulars such as unique product identification code, proper and generic name of the drug, brand name, name and address of the manufacturer, batch number, date of manufa,cturing and, expiry, and manufacturing license number.

In the first phase, 300 drugs from top pharma brands having around 35 percent of the total market share will be brought under this,s ambit and by December next year, all drugs may be covered.

The drugs include Allegra, Amlokind, Azithral, Betadine, Calpol, Ceftum, Combiflam, Dolo, Dulcoflex, Ecosprin, Gelusil, Jalra, Lantus, Manforce, Meftal Spaz, Shelcal, Human Mixtard, Pan 40, Otrivin, Pantocid, Rantac, Stamlo, T-bact ointment and unwanted kit and Volini spray.

The Drugs Technical Advisory Board (DTAB) in a meeting held in November 2021 had recomthe mended introduction of bar code or QR code in the top 300 brands of drug formulations.

Read also: These 300 medicines have been finalised for QR code